|
1. FDA approves pancreatic cancer drug that nearly doubles survival time Full story
2. FDA expands Mounjaro approval to reduce cardiovascular risk Full story
3. A patient’s financial instability can predict recovery as powerfully as medication adherence. Hear why that should change care delivery in this webinar.
4. AstraZeneca ends lung cancer drug trial: What to know Full story
5. GLP-1s and breast cancer: 5 things to know Full story
6. Only 18% of physicians are highly engaged. See what retention really requires here.
7. FDA approves 1st-of-its-kind drug for rare blood disorder Full story
8. Ifosfamide shortage turns ‘critical’; FDA to allow overseas imports Full story
Becker’s Learning Opportunities
9. Stop treating every stalled account as an isolated problem. Find the patterns. Start here.
10. Behavioral health conditions affect 30% of patients and they’re the hardest to guide to care. Tufts Medicine’s fix in this Sept. 18 webinar.
11. 42% of patients called their long stay preventable — yet stayed satisfied. The reason here.
12. Becker’s September webinar lineup: hospital AI, nonopioid pain care and analytics governance. See the sessions here.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
